Evidence map›Paper›PMID 29512465›Full record

ReviewCurrent neuropharmacology2018

Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options.

Emine Sekerdag, Ihsan Solaroglu, Yasemin Gursoy-Ozdemir

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05508113 (Effects of Ozone Autohemotherapy on Patients With Post-ischemic Stroke Insomnia), which is not on this map. Cited by 205 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
205citing papers in PubMed, 3 pooled it
17.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05508113 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Effects of Ozone Autohemotherapy on Patients With Post-ischemic Stroke Insomnia

TypeinterventionalSponsorMengmeng ChenRan2022 to 2022Enrolled60ConditionsPost-ischemic Stroke InsomniaArmsozone autohemotherapy
3 · Its place in the literature

Who cites it

205 citing papers in PubMed, 3 syntheses or guidelines pooled it, 365 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

145 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Emine SekerdagNeuroscience Research Lab, Research Center for Translational Medicine, Koç University, Istanbul, Turkey.
Ihsan SolarogluNeuroscience Research Lab, Research Center for Translational Medicine, Koç University, Istanbul, Turkey.
Yasemin Gursoy-OzdemirNeuroscience Research Lab, Research Center for Translational Medicine, Koç University, Istanbul, Turkey.
Koç University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a result of ischemia or hemorrhage, blood supply to neurons is disrupted which subsequently promotes a cascade of pathophysiological responses resulting in cell loss. Many mechanisms are involved solely or in combination in this disorder including excitotoxicity, mitochondrial death pathways, and the release of free radicals, protein misfolding, apoptosis, necrosis, autophagy and inflammation. Besides neuronal cell loss, damage to and loss of astrocytes as well as injury to white matter contributes also to cerebral injury. The core problem in stroke is the loss of neuronal cells which makes recovery difficult or even not possible in the late states. Acute treatment options that can be applied for stroke are mainly targeting re-establishment of blood flow and hence, their use is limited due to the effective time window of thrombolytic agents. However, if the acute time window is exceeded, neuronal loss starts due to the activation of cell death pathways. This review will explore the most updated cellular death mechanisms leading to neuronal loss in stroke. Ischemic and hemorrhagic stroke as well as subarachnoid hemorrhage will be debated in the light of cell death mechanisms and possible novel molecular and cellular treatment options will be discussed.

Indexed as

AnimalsCell- and Tissue-Based TherapyCell DeathHumansStrokeapoptosisautophagyhemorrhagic strokeIschemic strokenecrosisneuroprotective therapiespyroptosis.

Identifiers

PMID29512465
PMCPMC6251049
OpenAlexW2794215220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.